Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mindfulness and movement: new program aims to ease fatigue in advanced breast cancer

NCT ID NCT07238023

Recruiting now Symptom relief Sponsor: University of Oklahoma Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 31, 2026 · Updated 3 times

Summary

This study tests whether a remotely delivered program that combines mindfulness, physical activity tracking, and social support is acceptable and feasible for people with metastatic breast cancer. The program lasts 8-12 weeks and includes a wearable activity tracker and weekly challenges. Researchers will enroll 38 participants to see if the program is easy to use and enjoyable, and whether it helps improve well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Acceptance- and mindfulness-based physical activity promotion program
What this could lead to
If successful, this program could offer a practical, home-based way to help people with metastatic breast cancer stay active and improve their quality of life.
What could go wrong
This is a small, early feasibility study with only 38 participants and no control group, so results may not apply broadly. The program requires a smartphone and internet access, which may limit participation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC INVASIVE BREAST CANCER

Contacts and locations

Locations

  • TSET Health Promotion Research Center

    RECRUITING

    Oklahoma City, Oklahoma, 73104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.